-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, LFE3PXfTFs/xt4zXU+s+4mVRI5eHRCnZglx7tui/2SjfE51hz5yxc59Uoq7T/O5j C2t0xm0mi8IIQ0F/4I4fQw== 0001209191-04-058111.txt : 20041216 0001209191-04-058111.hdr.sgml : 20041216 20041216153240 ACCESSION NUMBER: 0001209191-04-058111 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20041215 FILED AS OF DATE: 20041216 DATE AS OF CHANGE: 20041216 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GUILFORD PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000918066 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521841960 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6611 TRIBUTARY ST CITY: BALTIMORE STATE: MD ZIP: 21224 BUSINESS PHONE: 4106316300 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MITCHELL DEAN J CENTRAL INDEX KEY: 0001199297 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23736 FILM NUMBER: 041208113 MAIL ADDRESS: STREET 1: C/O BRISTOL MYERS SQUIBB CO STREET 2: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10164 4 1 doc4.xml FORM 4 SUBMISSION X0202 4 2004-12-15 0 0000918066 GUILFORD PHARMACEUTICALS INC GLFD 0001199297 MITCHELL DEAN J 6611 TRIBUTARY STREET BALTIMORE MD 21224 1 1 0 0 President and C.E.O. Common Stock 2004-12-15 4 A 0 500000 5.60 A 550000 D Restricted Stock Units 5.60 2004-12-15 4 A 0 100000 5.60 A Common Stock 100000 100000 D Non-incentive Stock Option 5.64 2005-12-01 2014-12-01 Common Stock 1000000 1000000 D Includes 250,000 shares of restricted common stock that will become 100% vested one year from the date of Mr. Mitchell's employment with the Company, and 250,000 shares of restricted common stock that will become 100% vested seven years from the date of Mr. Mitchell's employment with the Company, or in 2007, 2008 and 2009 upon the achievement of certain performance milestones. Represents the maximum number of shares of common stock issuable to Mr. Mitchell pursuant to a grant of Restricted Stock Units, which will vest on the earlier of February 12, 2011 or the date of a change of control of the Company, and which shall equal an amount of shares equal to the quotient of $1 million divided by the average closing price for each trading day in the month preceding the issue date, but in no event shall be more than 100,000 shares. This option becomes exercisable to the extent of 25% of the shares underlying such option on the above date and is cumulatively exercisable to the extent of 1/36 of the remaining shares underlying such option each month thereafter. Asher M. Rubin, Attorney-in-fact 2004-12-16 -----END PRIVACY-ENHANCED MESSAGE-----